CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$6.46M |
| 3 |
Gilead Sciences
GILD
|
+$6.38M |
| 4 |
Amgen
AMGN
|
+$6.24M |
| 5 |
Adobe
ADBE
|
+$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$5.18M |
| 2 |
Analog Devices
ADI
|
+$3.75M |
| 3 |
Amazon
AMZN
|
+$3.48M |
| 4 |
lululemon athletica
LULU
|
+$3.4M |
| 5 |
iQIYI
IQ
|
+$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Paychex
PAYX
$48.7B
| $85.9K | 0.02% |
721
-622
| -46% | -$74.1K |
|
302
ALX Oncology
ALXO
$59.4M
| $85.8K | 0.02% |
5,762
+4,706
| +446% | +$70.1K |
|
303
American Electric Power
AEP
$57.5B
| $85.4K | 0.02% |
1,052
-868
| -45% | -$70.5K |
|
|
GRCL
304
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $84.4K | 0.02% |
8,405
+6,657
| +381% | +$66.8K |
|
305
Zymeworks
ZYME
$1.15B
| $84.2K | 0.02% |
+8,100
| New | +$84.2K |
|
|
SLRN
306
DELISTED
ACELYRIN
SLRN
| $84K | 0.02% |
+11,259
| New | +$84K |
|
307
OmniAb
OABI
$229M
| $83K | 0.02% |
+13,450
| New | +$83K |
|
308
Adaptive Biotechnologies
ADPT
$1.91B
| $82.1K | 0.02% |
16,747
+13,028
| +350% | +$63.8K |
|
|
FUSN
309
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $80.5K | 0.02% |
+8,376
| New | +$80.5K |
|
310
Edgewise Therapeutics
EWTX
$1.57B
| $80.3K | 0.02% |
7,338
+5,704
| +349% | +$62.4K |
|
|
DDL
311
Dingdong
DDL
$486M
| $80.3K | 0.02% |
53,514
| – | – |
|
312
Vera Therapeutics
VERA
$1.58B
| $79.1K | 0.02% |
+5,143
| New | +$79.1K |
|
313
Travere Therapeutics
TVTX
$1.89B
| $78.1K | 0.02% |
8,690
+6,773
| +353% | +$60.9K |
|
314
Alector
ALEC
$279M
| $77.7K | 0.02% |
9,733
+7,584
| +353% | +$60.5K |
|
315
Tarsus Pharmaceuticals
TARS
$2.4B
| $77.6K | 0.02% |
3,832
+3,004
| +363% | +$60.8K |
|
316
Avidity Biosciences
RNA
$6.18B
| $77.6K | 0.02% |
8,570
+6,675
| +352% | +$60.4K |
|
317
Cognizant
CTSH
$34.8B
| $75.5K | 0.01% |
1,000
-882
| -47% | -$66.6K |
|
318
Constellation Energy
CEG
$93.4B
| $74K | 0.01% |
633
-565
| -47% | -$66K |
|
319
Savara
SVRA
$665M
| $73.6K | 0.01% |
+15,654
| New | +$73.6K |
|
320
Electronic Arts
EA
$42B
| $73.2K | 0.01% |
535
-474
| -47% | -$64.8K |
|
321
Fastenal
FAST
$55.3B
| $73K | 0.01% |
2,254
-2,004
| -47% | -$64.9K |
|
|
BCYC
322
Bicycle Therapeutics
BCYC
$485M
| $72.3K | 0.01% |
4,001
+3,322
| +489% | +$60.1K |
|
323
Exelon
EXC
$43.4B
| $71.9K | 0.01% |
2,003
-1,705
| -46% | -$61.2K |
|
324
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $71.9K | 0.01% |
4,097
+3,186
| +350% | +$55.9K |
|
325
CoStar Group
CSGP
$37.3B
| $71.3K | 0.01% |
816
-706
| -46% | -$61.7K |
|